Smyth, P.Ferguson, L.Burrows, J. F.Burden, R. E.Tracey, S. R.Herron, M.Kovaleva, M.Williams, R.Porter, A. J.Longley, D. B.Barelle, C. J.Scott, C. J.2024-01-302024-01-302023-12-05Smyth, P, Ferguson, L, Burrows, J F, Burden, R E, Tracey, S R, Herron, M, Kovaleva, M, Williams, R, Porter, A J, Longley, D B, Barelle, C J & Scott, C J 2023, 'Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy', Frontiers in Pharmacology, vol. 14, 1296567. https://doi.org/10.3389/fphar.2023.12965671663-9812https://hdl.handle.net/2164/22667Funding Information: The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded through a grant from the BBSRC (BB/R009112/1).132554269engSDG 3 - Good Health and Well-beingcancercathepsininhibitortherapeuticvNARRM Therapeutics. PharmacologyPharmacologyPharmacology (medical)Biotechnology and Biological Sciences Research Council (BBSRC)BB/R009112/1RMJournal article10.3389/fphar.2023.1296567http://www.scopus.com/inward/record.url?scp=85180124183&partnerID=8YFLogxK14